Attorney Generals call on Congress to classify xylazine as controlled substance

Author: Chris Galford

Fearing the proliferation of illicit versions of the drug xylazine – or tranq – and its effects on the U.S. public, the National Association of Attorneys General (NAAG) wrote to Congressional leaders last week urging passage of the Combating Illicit Xylazine Act (H.R. 1839).

The legislation would officially classify xylazine as a controlled substance. Unlike other items involved in the overdose troubles facing the country, xylazine is notable for being a non-opioid. In fact, it is a veterinary tranquilizer meant for large animals such as horses or deer and was never approved or accepted as a medical solution for humans. However, it is not currently a federally designated controlled substance.

Read more on:

Wonder why they didn’t write to the DEA. Thought Congress gave the DEA sole power to classify medication schedules so that Congress didn’t have to get involved each time. I’m sure there’s some reason for them going directly to the DEA.